Select a medication above to begin.
primaquine phosphate
generic
Adult Dosing .
Dosage forms: TAB: 26.3 mg
Special Note
- [strength clarification]
- Info: 26.3 mg primaquine phosphate = 15 mg primaquine base; doses expressed as primaquine phosphate
malaria antirelapse tx
- [52.6 mg PO qd x14 days]
- Info: give after uncomplicated malaria tx for P. vivax or P. ovale; in pts >70 kg, give 10.5 mg/kg per tx course divided into 52.6 mg daily doses, max 52.6 mg/day; if intermediate G6PD deficiency, may give 78.9 mg PO qwk x8wk; refer to CDC guidelines
malaria prophylaxis, primary (off-label)
- [52.6 mg PO qd]
- Start: 1-2 days before exposure; Info: for short duration travel to areas w/ primarily P. vivax; D/C 7 days after exposure; see CDC Pre-Travel Malaria Prophylaxis recommendations in Guidelines > Specialties > Infectious Diseases
malaria prophylaxis, terminal (off-label)
- [52.6 mg PO qd x14 days]
- Start: after leaving malarious area; Info: for presumptive antirelapse tx (PART) to prevent relapses or delayed-onset P. vivax and P. ovale malaria after prolonged exposure; refer to CDC Yellow Book
PCP (off-label)
- [52.6 mg PO qd]
- Info: not 1st-line agent; give w/ clindamycin
renal dosing
- [no adjustment]
- renal impairment: no adjustment
- HD/PD: no adjustment; no supplement
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: TAB: 26.3 mg
Special Note
- [strength clarification]
- Info: 26.3 mg primaquine phosphate = 15 mg primaquine base; doses expressed as primaquine phosphate
malaria antirelapse tx (off-label)
- [0.8 mg/kg/dose PO qd x14 days]
- Max: 52.6 mg/day; Info: give after uncomplicated malaria tx for P. vivax or P. ovale; in pts >70 kg, give 10.5 mg/kg per tx course divided into 52.6 mg daily doses, max 52.6 mg/day; if intermediate G6PD deficiency, may give 1.2 mg/kg/dose PO qwk x8wk, max 78.9 mg/dose; refer to CDC guidelines
malaria prophylaxis, primary (off-label)
- [0.8 mg/kg/dose PO qd]
- Start: 1-2 days before exposure; Max: 52.6 mg/day; Info: for short duration travel to areas w/ primarily P. vivax; D/C 7 days after exposure; see CDC Pre-Travel Malaria Prophylaxis recommendations in Guidelines > Specialties > Infectious Diseases
malaria prophylaxis, terminal (off-label)
- [0.8 mg/kg/dose PO qd x14 days]
- Start: after leaving malarious area; Max: 52.6 mg/day; Info: for presumptive antirelapse tx (PART) to prevent relapses or delayed-onset P. vivax and P. ovale malaria after prolonged exposure; refer to CDC Yellow Book
renal dosing
- [not defined]
- renal impairment: consider adult renal dosing for guidance
- HD/PD: consider adult renal dosing for guidance
hepatic dosing
- [not defined]